Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India Global Trial Hub Dreams Still Distant As Concerns Linger

Executive Summary

Indian clinical trial approvals appear to be on the downswing despite government moves to boost the troubled sector, as regulatory uncertainty and negative publicity continue to undermine confidence in the industry.

Advertisement

Related Content

India’s Micro Therapeutic says EMA’s ‘Sweep’ Suspension Will Hurt; CRO Industry Shuns ‘Bad Eggs’
Another Indian CRO Under EMA Lens Over Dirty Data Concerns
Indian Clinical Research Sector: Hope And Despair Amid Shutdowns
The ECG curse: India's Quest under lens in ''retrospective'' finding
Who's doing what on EMA call for generics suspension after Indian CRO data manipulation
Faced With An Adverse Verdict, India’s Clinical Research Industry Pushes For A Quick Makeover

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS118953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel